388 related articles for article (PubMed ID: 7510098)
21. Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue.
Warren KG; Catz I
J Neurol Sci; 1993 Apr; 115(2):169-76. PubMed ID: 7683331
[TBL] [Abstract][Full Text] [Related]
22. Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein.
Warren KG; Catz I
J Neurol Sci; 1991 May; 103(1):90-6. PubMed ID: 1713953
[TBL] [Abstract][Full Text] [Related]
23. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis.
Link J; Fredrikson S; Söderström M; Olsson T; Höjeberg B; Ljungdahl A; Link H
Ann Neurol; 1994 Feb; 35(2):197-203. PubMed ID: 7509140
[TBL] [Abstract][Full Text] [Related]
24. CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10.
Biddison WE; Cruikshank WW; Center DM; Pelfrey CM; Taub DD; Turner RV
J Immunol; 1998 Jan; 160(1):444-8. PubMed ID: 9552002
[TBL] [Abstract][Full Text] [Related]
25. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
26. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
[TBL] [Abstract][Full Text] [Related]
27. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
O'Connor KC; Lopez-Amaya C; Gagne D; Lovato L; Moore-Odom NH; Kennedy J; Krupp L; Tenembaum S; Ness J; Belman A; Boyko A; Bykova O; Mah JK; Stoian CA; Waubant E; Kremenchutzky M; Ruggieri M; Bardini MR; Rensel M; Hahn J; Weinstock-Guttman B; Yeh EA; Farrell K; Freedman MS; Iivanainen M; Bhan V; Dilenge M; Hancock MA; Gano D; Fattahie R; Kopel L; Fournier AE; Moscarello M; Banwell B; Bar-Or A
J Neuroimmunol; 2010 Jun; 223(1-2):92-9. PubMed ID: 20381173
[TBL] [Abstract][Full Text] [Related]
28. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
29. [Neurofilament protein light in multiple sclerosis].
Zhang Y; Li X; Qiao J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
[TBL] [Abstract][Full Text] [Related]
30. Myelin proteolipid protein, basic protein, the small isoform of myelin-associated glycoprotein, and p42MAPK are associated in the Triton X-100 extract of central nervous system myelin.
Arvanitis DN; Yang W; Boggs JM
J Neurosci Res; 2002 Oct; 70(1):8-23. PubMed ID: 12237860
[TBL] [Abstract][Full Text] [Related]
31. Interaction of myelin basic protein and proteolipid protein.
Edwards AM; Ross NW; Ulmer JB; Braun PE
J Neurosci Res; 1989 Jan; 22(1):97-102. PubMed ID: 2467009
[TBL] [Abstract][Full Text] [Related]
32. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
34. Epitopes of immunoreactive myelin basic protein in human cerebrospinal fluid.
Whitaker JN; Gupta M; Smith OF
Ann Neurol; 1986 Sep; 20(3):329-36. PubMed ID: 2429613
[TBL] [Abstract][Full Text] [Related]
35. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
36. Molecular and cellular determinants of neuroimmunologic inflammatory disease.
Paterson PY
Fed Proc; 1982 Jul; 41(9):2569-76. PubMed ID: 6177557
[TBL] [Abstract][Full Text] [Related]
37. MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis.
Sellebjerg F; Christiansen M; Garred P
Mult Scler; 1998 Jun; 4(3):127-31. PubMed ID: 9762660
[TBL] [Abstract][Full Text] [Related]
38. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
[TBL] [Abstract][Full Text] [Related]
39. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis.
Catz I; Warren KG
Can J Neurol Sci; 1986 Feb; 13(1):21-4. PubMed ID: 2420428
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness.
Davies L; McLeod JG; Muir A; Hensley WJ
Clin Exp Neurol; 1987; 24():5-10. PubMed ID: 2478320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
